Stanisław R. Burzyński

879 total citations
69 papers, 687 citations indexed

About

Stanisław R. Burzyński is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Stanisław R. Burzyński has authored 69 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 22 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in Stanisław R. Burzyński's work include Glioma Diagnosis and Treatment (30 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Cancer Treatment and Pharmacology (13 papers). Stanisław R. Burzyński is often cited by papers focused on Glioma Diagnosis and Treatment (30 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Cancer Treatment and Pharmacology (13 papers). Stanisław R. Burzyński collaborates with scholars based in Poland, United States and Switzerland. Stanisław R. Burzyński's co-authors include A. Marszałek, Sonali Patil, Mohammad I. Khan, Lawrence B. Hendry, Thomas G. Muldoon, John A. Copland, Magdalena Szopa, R Lewy, Andreas F. Lehner and Samuel W. Beenken and has published in prestigious journals such as JAMA, Analytical Biochemistry and Cellular and Molecular Life Sciences.

In The Last Decade

Stanisław R. Burzyński

57 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stanisław R. Burzyński Poland 15 388 252 183 176 162 69 687
Bente Sandvei Skeie Norway 12 235 0.6× 272 1.1× 115 0.6× 137 0.8× 266 1.6× 18 781
Maria Piribauer Austria 13 341 0.9× 169 0.7× 42 0.2× 105 0.6× 113 0.7× 16 549
Laurine E. Wedekind Netherlands 12 244 0.6× 265 1.1× 54 0.3× 127 0.7× 67 0.4× 15 504
Nagendra K. Chaturvedi United States 18 166 0.4× 482 1.9× 55 0.3× 144 0.8× 85 0.5× 42 775
Elias A. El-Habr France 14 128 0.3× 267 1.1× 28 0.2× 130 0.7× 57 0.4× 21 484
C. Loesberg Netherlands 11 73 0.2× 264 1.0× 126 0.7× 74 0.4× 60 0.4× 21 717
Harvey Schlesinger United States 10 33 0.1× 318 1.3× 299 1.6× 105 0.6× 43 0.3× 13 568
Bhaswati Sarcar United States 12 133 0.3× 418 1.7× 14 0.1× 142 0.8× 67 0.4× 19 675
Mitsuya Hanatani Japan 9 35 0.1× 219 0.9× 168 0.9× 44 0.3× 33 0.2× 9 529
Lindsay Stetson United States 10 264 0.7× 325 1.3× 14 0.1× 93 0.5× 123 0.8× 15 621

Countries citing papers authored by Stanisław R. Burzyński

Since Specialization
Citations

This map shows the geographic impact of Stanisław R. Burzyński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanisław R. Burzyński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanisław R. Burzyński more than expected).

Fields of papers citing papers by Stanisław R. Burzyński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanisław R. Burzyński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanisław R. Burzyński. The network helps show where Stanisław R. Burzyński may publish in the future.

Co-authorship network of co-authors of Stanisław R. Burzyński

This figure shows the co-authorship network connecting the top 25 collaborators of Stanisław R. Burzyński. A scholar is included among the top collaborators of Stanisław R. Burzyński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanisław R. Burzyński. Stanisław R. Burzyński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Burzyński, Stanisław R., et al.. (2019). Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted Therapy. 8(1). 1–1. 6 indexed citations
3.
4.
5.
Burzyński, Stanisław R., et al.. (2015). A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Primary Brain Tumors—Final Report (Protocol BT-09). Journal of Cancer Therapy. 6(12). 1063–1074. 6 indexed citations
6.
Burzyński, Stanisław R., et al.. (2015). Complete Response and Long-Term Survival (>20 Years) of a Child with Tectal Glioma: A Case Report. Pediatric Neurosurgery. 50(2). 99–103. 7 indexed citations
7.
8.
Burzyński, Stanisław R., et al.. (2014). Recurrent Glioblastoma Multiforme—A Strategy for Long-Term Survival. Journal of Cancer Therapy. 5(10). 957–976. 22 indexed citations
9.
Burzyński, Stanisław R., et al.. (2014). Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Advanced Malignant Mesothelioma: A Strategy for Improved Survival. Journal of Cancer Therapy. 5(12). 1127–1144. 1 indexed citations
10.
11.
Burzyński, Stanisław R., Jerzy Paleolog, Grzegorz Borsuk, et al.. (2013). Changed gene expression and longevity in honeybees (Apis mellifera) fed with phenylbutyrate- and phenylacetylglutaminate-supplemented diet. Medycyna Weterynaryjna. 69(12). 753–759. 6 indexed citations
12.
Burzyński, Stanisław R.. (2012). Stanislaw R. Burzynski, MD, PhD: novel cancer research and the fight to prove its worth.. PubMed. 18(3). 54–61. 1 indexed citations
13.
Paleolog, Jerzy, Aneta Strachecka, Stanisław R. Burzyński, Krzysztof Olszewski, & Grzegorz Borsuk. (2011). The larval diet supplemented with sodium phenylacetylglutaminate influences the worker cuticle proteolytic system in honeybees (Apis mellifera). Journal of Apicultural Science. 55(2). 7 indexed citations
14.
Burzyński, Stanisław R.. (2006). Treatments for Astrocytic Tumors in Children. Pediatric Drugs. 8(3). 167–178. 42 indexed citations
15.
Burzyński, Stanisław R., et al.. (2004). Phase II Study of Antineoplaston A10 and AS2-1 in Children with Recurrent and Progressive Multicentric Glioma. Drugs in R&D. 5(6). 315–326. 6 indexed citations
16.
Burzyński, Stanisław R., et al.. (2003). Phase II Study of Antineoplaston A10 and AS2-1 in Patients with Recurrent Diffuse Intrinsic Brain Stem Glioma. Drugs in R&D. 4(2). 91–101. 8 indexed citations
17.
Burzyński, Stanisław R., et al.. (1995). Cellular accumulation of antineoplaston AS21 in human hepatoma cells. Cancer Letters. 88(1). 107–112. 6 indexed citations
18.
Burzyński, Stanisław R., et al.. (1990). Treatment of hormonally refractory cancer of the prostate with antineoplaston AS2-1.. PubMed. 16(7). 361–9. 9 indexed citations
19.
Szopa, Magdalena, et al.. (1987). Quantitative assay of plasma and urinary peptides as an aid for the evaluation of cancer patients undergoing antineoplaston therapy.. PubMed. 13 Suppl 1. 61–70. 8 indexed citations
20.
Burzyński, Stanisław R.. (1976). Sequential analysis in subnanomolar amounts of peptides. Determination of the structure of a habituation-induced brain peptide (ameletin). Analytical Biochemistry. 70(2). 359–365. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bente Sandvei Skeie Breakdown of academic impact, for papers by Maria Piribauer Breakdown of academic impact, for papers by Laurine E. Wedekind Breakdown of academic impact, for papers by Nagendra K. Chaturvedi Breakdown of academic impact, for papers by Elias A. El-Habr Breakdown of academic impact, for papers by C. Loesberg Breakdown of academic impact, for papers by Harvey Schlesinger Breakdown of academic impact, for papers by Bhaswati Sarcar Breakdown of academic impact, for papers by Mitsuya Hanatani Breakdown of academic impact, for papers by Lindsay Stetson
Rankless by CCL
2026